摘要: Hepatitis C is a major health care problem plagued by the lack of truly effective therapy. To date, combination interferon and ribavirin has provided best chance viral eradication. However, this therapy expensive, multiple side effects works in less than half patients. New strategies need to be developed deal with increasing burden hepatitis C-related disease, we anxiously await arrival new drugs such as helicase protease inhibitors.